Replimune director granted 44,500 stock options
Replimune Group, Inc. director Veleka Peeples-Dyer received a grant of stock options covering 44,500 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Replimune Group, Inc. director Veleka Peeples-Dyer received a grant of stock options covering 44,500 shares of common stock. The options have an exercise price of $7.61 per share and expire on April 1, 2036. All underlying shares vest on April 1, 2027, making this a compensation-related, non-market transaction.
Insider Trade Summary
Grant/Award: 44,500 shares
Grant/Award
1 txn
Insider
Peeples-Dyer Veleka
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 44,500 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 44,500 contracts (Direct)
Footnotes (1)
- F1. The shares underlying this option vest entirely on April 1, 2027.
Key Figures
Option shares granted: 44,500 options
Exercise price: $7.61 per share
Underlying shares: 44,500 shares
+3 more
6 metrics
Option shares granted
44,500 options
Total stock options awarded to director
Exercise price
$7.61 per share
Option exercise price for underlying common stock
Underlying shares
44,500 shares
Replimune common stock underlying the options
Vesting date
April 1, 2027
All underlying shares vest on this date
Expiration date
April 1, 2036
Options expire if not exercised by this date
Options held after grant
44,500 options
Total options reported following this transaction
Key Terms
Stock Option (right to buy), exercise price, expiration date, underlying security, +2 more
6 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 7.6100"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-04-01T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
vest financial
"The shares underlying this option vest entirely on April 1, 2027."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Replimune (REPL) director Veleka Peeples-Dyer report in this Form 4?
The Form 4 shows that director Veleka Peeples-Dyer received a grant of stock options for 44,500 Replimune common shares. These options are compensation-related, not an open-market purchase or sale, and give her the right to buy shares at a fixed exercise price.
What is the exercise price of the new Replimune (REPL) stock options?
The options have an exercise price of $7.61 per share. This means Peeples-Dyer can choose to buy up to 44,500 Replimune common shares at $7.61 each, regardless of the market price, once the options have vested and before they expire.
When do Veleka Peeples-Dyer’s Replimune (REPL) options vest and expire?
All shares underlying this option vest on April 1, 2027. After vesting, the options remain exercisable until their stated expiration date of April 1, 2036, giving a long window for potential exercise, subject to plan and employment terms.
Does this Replimune (REPL) Form 4 reflect an open-market stock purchase or sale?
No, the Form 4 reflects a grant of stock options classified as a grant or award acquisition. It is not an open-market buy or sell transaction; instead, it is part of director compensation, with shares potentially acquired later upon exercise.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates